Skip to main content

Table 1 Summary of genomic studies on gastric cancer (GC)

From: Genomic alterations and molecular subtypes of gastric cancers in Asians

Reference

Sample size

Ethnicity

Histology (Lauren’s type)

Technology platform

Molecular subtype

Intestinal

Diffuse

Mixed

Not specified

WES

WGS

RNAseq

SNP/copy number microarray

Targeted sequencing

Gene expression microarray

DNA methylation profiling

[10]

49 (MSS only)

Korean

18

31

0

0

 

√

     

NA

[14]

294

Northern Chinese

139

155

0

0

√

√

  

√

  

High clonality and low clonality

[16]

75

Asian

196

69

19

11

√

√

√

√

  

√

EBV+, MSI, GS, and CIN

220

Non-Asian

[17]

890

Asian

0

0

0

1016

     

√

 

NA

126

Non-Asian

[18]

100

Chinese (Hong Kong)

57

29

14

0

 

√

 

√

 

√

√

NA

[22]

386

Singaporean

253

183

82

3

     

√

 

Genomic intestinal and genomic diffuse

65

Korean

70

Australian

[23]

19

Korean

5

14

0

0

√

√

     

NA

[24]

300

Korean

150

142

8

0

   

√

√

√

 

MSS/TP53−, MSS/TP53+, MSS/EMT, and MSI

[25]

103

Korean

61

36

5

1

√

  

√

   

NA

[26]

22

Chinese (Hong Kong)

18

2

2

0

√

      

NA

[27]

15

Singaporean

11

3

1

0

√

  

√

 

√

 

NA

[28]

87

Japanese

0

87

0

0

√

   

√

  

NA

[29]

36

Non-Asian

12

10

14

0

     

√

 

Proximal non-diffuse, diffuse, and distal non-diffuse

[30]

17

Non-Asian

0

0

0

51

√

 

√

√

   

NA

34

Vietnamese

[31]

116

Non-Asian

12

24

0

80

    

√

  

NA

  1. WES whole-exome sequencing, WGS whole-genome sequencing, RNAseq RNA sequencing, SNP single-nucleotide polymorphism, MSS microsatellite stable, NA not available, EBV, Epstein-Barr virus, MSI microsatellite instability, GS genomically stable, CIN chromosomal instability, TP53 tumor protein 53, EMT epithelial-to-mesenchymal transition